Skip to content
knowrare
HealthSignal
Your condition community

Living with Autosomal dominant nonsyndromic hearing loss 22

An inherited form of hearing loss that is passed down in families.

Understanding Autosomal dominant nonsyndromic hearing loss 22

Autosomal dominant nonsyndromic hearing loss 22 (DFNA22) is a type of hearing loss that is passed down in families.

DFNA22 is a type of deafness that runs in families. GARD does not list other details such as when it starts or how it changes over time.

Signs & symptoms

GARD doesn't list specific symptoms for this condition yet, but hearing loss is the main feature.

  • Hearing loss

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Your doctor may refer you to a specialist who knows rare conditions.

  3. Ask which tests can help

    Your care team will decide which exams and tests can confirm the diagnosis.

Care & treatment

Care team
A doctor familiar with rare conditions, plus specialists as needed
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with rare disease patient organizations for support
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Can genetic testing for the MYO6 gene confirm my diagnosis?
How often should my hearing be checked?
Should my relatives consider genetic testing?

Quick facts

InheritanceAutosomal Dominant

It is caused by a change in the MYO6 gene (myosin VI) on chromosome 6. A change in just one copy of the gene can lead to DFNA22.

Also known as: autosomal dominant nonsyndromic deafness 22; dfna 22; dfna22 nonsyndromic hearing loss and deafness

Patient organizations

Rare-disease groups that can help

Source: NIH GARD · Autosomal dominant nonsyndromic hearing loss 22GARD ID 9167 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Autosomal dominant nonsyndromic hearing loss 22.

Explore the Autosomal dominant nonsyndromic hearing loss 22 blog

Explore research for Autosomal dominant nonsyndromic hearing loss 22

Explore actively recruiting Autosomal dominant nonsyndromic hearing loss 22 studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Autosomal dominant nonsyndromic hearing loss 22 with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Autosomal dominant nonsyndromic hearing loss 22 studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Autosomal dominant nonsyndromic hearing loss 22

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Autosomal dominant nonsyndromic hearing loss 22

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Autosomal dominant nonsyndromic hearing loss 22 experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.